Primary care should seek to identify and provide proactive support to older people living with frailty.
In this article Lisa Cummings, Queens Nurse, CYP Specialist Asthma Practitioner and PCRS Education Committee member, discusses the management of asthma and atopy in children and young people focusing on perennial and allergic rhinitis, it’s impact on asthma and top tips for reducing symptoms and
In this article, the authors provide a pragmatic consensus approach to calculating and interpreting peak expiratory flow rate (PEFR) variability and reversibility from peak flow diary recordings for asthma diagnosis. This guide is intended for healthcare professionals working in primary care.
Sixteen years ago I was diagnosed with COPD. My COPD means I get breathless very quickly now doing activities or things I previously did easily without and difficulty.
Respiratory infections are very common in winter and can be complex to assess.
Bronchoscopic and surgical treatments for people with COPD can improve their lung and exercise capacity, and quality and length of life for many years in addition to what medical treatments can achieve.
PCRS advocate a pragmatic approach to the pharmacological management of patients with COPD guided by the predominance of breathlessness and/or exacerbations and the presence or absence of comorbid asthma.
In this article the authors review current evidence and guidance for the treatment of Chronic obstructive pulmonary disease (COPD) in order to bring up to date the Primary Care Respiratory Society (PCRS) consensus approach and algorithm first published in 2017 known as ‘Keeping it Simple’.
Spirometry is a component of the diagnosis and management of respiratory conditions in primary care and should ideally be performed via referral to a primary care network respiratory diagnostic service or community diagnostics centre (CDC) with expertise in the diagnosis of the most common respir
This update from PCRU guest editor and PCRS Executive Chair, Katherine Hickman, gives an overview of the latest edition of the update.
In this edition, we focus on COPD and revisit the 2017 PCRS consensus on COPD treatment titled 'Keeping it Simple.' The updated algorithm aligns with the latest GOLD and NICE guidance, and maintains a focus on patient-centred treatment grounded in evidence, medication optimisation, and continuous
In 2023, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved the use of a dual (Inhaled corticosteroid/ Formoterol) combination treatment to be used as a reliever therapy for people aged 12 and over with the therapy choice situated early in the asthma treatment pathway as an a
The PCRS Patient Reference Group (PRG) is a small group of people with respiratory conditions who support PCRS to ensure that we always try to embed the patient perspective in our work and consider the holistic management of patients.